Penumbra Quarterly Cash Flow Statement
NYSE: PENHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Penumbra free cash flow
In the quarter ended Jun 30, 2026, Penumbra generated $46.1 million of operating cash flow and spent $13.5 million on capital expenditures. That left free cash flow of $32.5 million, a free-cash-flow margin of 8.3% of revenue. Free cash flow was up 10.8% from the prior year's $29.4 million.
Summary generated from market data by MetaCap's automated system. Methodology
Penumbra cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 34.81M | 32.58M | 47.34M | 45.85M | 45.27M | 39.22M | 33.68M | 29.53M | -60.20M | 11.00M | 54.22M | 9.21M |
| Net Income growth (YoY) | -23.10% | -16.93% | +40.55% | +55.28% | — | +256.51% | -37.87% | +220.46% | -417.51% | +28.50% | +1298.45% | — |
| Depreciation & Amortization | 5.62M | 4.57M | 4.46M | 2.49M | 5.51M | 5.01M | 4.39M | 4.15M | 7.65M | 7.52M | 7.04M | 6.93M |
| Stock-Based Compensation | 13.66M | 14.64M | 15.26M | 15.93M | 14.23M | 13.79M | 12.10M | 10.94M | 9.56M | 13.57M | 10.79M | 14.14M |
| Change in Working Capital | -26.08M | 18.53M | 1.49M | -27.33M | -19.22M | -10.57M | -22.98M | 2.49M | -23.96M | 6.62M | -24.48M | -20.97M |
| Operating Cash Flow | 46.08M | 86.97M | 86.48M | 58.26M | 44.95M | 48.97M | 51.11M | 56.47M | 22.61M | 38.30M | 36.26M | 30.84M |
| Capital Expenditures | -13.54M | -13.67M | -18.43M | -16.25M | -15.58M | -13.47M | -5.37M | -5.45M | -4.54M | -5.82M | -3.65M | -3.33M |
| Investing Cash Flow | -91.09M | -30.63M | -225.65M | -162.86M | -15.58M | -502.00K | -10.96M | 35.72M | 34.47M | 18.38M | 24.28M | -44.40M |
| Share Repurchases | — | — | 0 | — | — | — | 1.00K | — | — | — | 0 | — |
| Financing Cash Flow | 9.03M | -1.91M | 5.06M | 3.95M | 14.82M | 2.71M | 6.07M | -100.55M | 8.27M | -794.00K | 5.92M | 212.00K |
| Net Change in Cash | -36.02M | 54.39M | -134.13M | -100.74M | 45.71M | 51.65M | 43.93M | -7.86M | 65.22M | 55.63M | 66.73M | -13.41M |
| Free Cash Flow | 32.54M | 73.30M | 68.05M | 42.01M | 29.37M | 35.50M | 45.74M | 51.02M | 18.07M | 32.47M | 32.62M | 27.51M |
This table shows 12 quarterly periods of Penumbra's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PEN's reporting calendar. What is a cash flow statement?